Company: PAII-WT
Filing Date: 2025-05-29
Form Type: DRS
Source: 0001213900-25-049013
Chunk: 4

Company: Pyrophyte Acquisition Corp. II
Filing Date: 2025-05-29
Form: DRS
Chunk 4
---
 | $  10,500,000 |
| Proceeds, before expenses, to us:       |  $  9.40 |  $164,500,000 |

(1)Includes (a) $0.15 per unit sold in the base offering, or $2,625,000, payable to the underwriters upon the closing of this offering and (b) $0.45 per unit sold in the base offering, or $7,875,000, for deferred underwriting commissions to be placed in a trust account located in the United States and released to UBS only upon the completion of an initial business combination. If the underwriters’ over -allotmentoption is exercised, $0.60 per over -allotmentunit, or up to an additional $1,575,000 (or $9,450,000 in the aggregate if the underwriters’ over -allotmentoption is exercised in full), will be deposited in the trust account as deferred underwriting commissions and released to UBS only upon the completion of an initial business combination. See “ Underwriting” for additional information regarding underwriting compensation. Of the proceeds we receive from this offering and the sale of the private placement warrants described in this prospectus, $175,000,000, or $201,250,000 if the underwriters’ over -allotmentoption is exercised in full ($10.00 per unit in either case), will be placed into a U.S. -basedtrust account with Continental Stock Transfer & Trust Company acting as trustee. Our sponsor, Pyrophyte Acquisition II LLC, currently holds an aggregate of 7,255,952 Class B ordinary shares (up to 946,428 of which are subject to forfeiture by our sponsor depending on the extent to which the underwriters’ over -allotmentoption is exercised) that were initially purchased by our sponsor for an aggregate purchase price of $25,000, or approximately $0.003 per share. The Class B ordinary shares will automatically convert into Class A ordinary shares immediately prior to, concurrently with or immediately following the consummation of our initial business combination, or at any time prior thereto at the option of the holder thereof, on a one -for -onebasis, subject to adjustment as provided herein. In the case that additional Class A ordinary shares, or equity -linkedsecurities (as described herein), are issued or deemed issued in excess of the amounts issued in this offering and related to the closing of our